Cell Chemical Biology

Papers
(The H4-Index of Cell Chemical Biology is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Antisense-mediated senseful regulation of orchestrated metabolic response108
New sheriff in town: Cyclic peptide inhibitors of a DUB module93
CBLs downregulation foretells T cell ubiquitination leading to autoimmunity76
Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples71
Therapeutic potential of inhibiting the PI3Kγ complex for leukemia69
Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 167
A versatile residue numbering scheme for Nav and Cav channels65
ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas65
Control of topoisomerase II activity and chemotherapeutic inhibition by TCA cycle metabolites63
Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation63
Meet the Authors: Christopher R. Mansfield and Emily R. Derbyshire61
FADS2-dependent fatty acid desaturation dictates cellular sensitivity to ferroptosis and permissiveness for hepatitis C virus replication59
Voices: Challenges and opportunities in regulating the immune system59
Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance58
Heterologous characterization of mechercharmycin A biosynthesis reveals alternative insights into post-translational modifications for RiPPs58
Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine57
A genome-wide CRISPR-Cas9 screen identifies CENPJ as a host regulator of altered microtubule organization during Plasmodium liver infection55
Advances in spatial proteomics: Mapping proteome architecture from protein complexes to subcellular localizations55
Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development55
Next steps for targeted protein degradation54
2′-OH as a universal handle for studying intracellular RNAs54
Scribble sub-cellular localization modulates recruitment of YES1 to regulate YAP1 phosphorylation53
Target deconvolution with matrix-augmented pooling strategy reveals cell-specific drug-protein interactions51
Peptide-mediated inhibition of the transcriptional regulator Elongin BC induces apoptosis in cancer cells51
Catalytic spike antibodies: A new paradigm in neutralization49
Beyond antibiotic resistance: The whiB7 transcription factor coordinates an adaptive response to alanine starvation in mycobacteria48
Meet the Cell Chemical Biology author and newest advisory board member: Marcus Conrad47
Meet the Authors: Harkamal S. Jhajj and Peter M. Tessier47
Mechanisms by which microbiome-derived metabolites exert their impacts on neurodegeneration47
Real-time non-invasive fluorescence imaging of gut commensal bacteria to detect dynamic changes in the microbiome of live mice46
A complex puzzle: Regulation of SLFN12 RNase activity by phosphorylation45
Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy45
N6-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis44
A fine-tuned azobenzene for enhanced photopharmacology in vivo43
A synthetic RNA-based biosensor for fructose-1,6-bisphosphate that reports glycolytic flux41
PALP: A rapid imaging technique for stratifying ferroptosis sensitivity in normal and tumor tissues in situ41
Probing the binding of interleukin-23 to individual receptor components and the IL-23 heteromeric receptor complex in living cells using NanoBRET40
PROTAC-mediated degradation of HIV-1 Nef efficiently restores cell-surface CD4 and MHC-I expression and blocks HIV-1 replication40
Peripherally active dextromethorphan derivatives lower blood glucose levels by targeting pancreatic islets40
Pharmacological management of disease by overcoming structural adversity40
0.043973922729492